Education

Sep, 2011—Jun,2014  Tianjin Medical University  Immunology  MD, PhD

Sep, 2000—Jun,2003  Tianjin Medical University  Clinical laboratory diagnosis  Master

Sep, 1995—Jun,2000  Tianjin Medical University  Medical Laboratory  Bachelor

Awards

2010 Champion of “Tianjin Health Industry First Training and Technical Competition”.

2010 The third prize in the “6th National Conference on Young and Middle-aged Laboratory Medicine”.

2011  “Outstanding Paper Award” in the “Ninth National Conference on Laboratory Medicine” of the Chinese Medical Association.

2012 “Outstanding Paper Award” in the “The 7th National Conference on Young and Middle-aged Laboratory Medicine of the Chinese Medical Association”.

2013 “Excellent Paper Award” in the “10th National Conference on Laboratory Medicine” of the Chinese Medical Association.

2015 “Excellent Poster Award” at the “11th National Conference on Laboratory Medicine” of the Chinese Medical Association.

2015 “Excellent Paper Award” in the “Seventh North China Three Provinces and Two Cities Inspection Medicine Academic Conference”.

2016 “Excellent Paper Award” in the “Tianjin Medical Association 8th Academic Conference on Laboratory Medicine”.

2017 The honor of the “Second Prize for Guiding Graduate Excellent Papers” in “First Great Wall Inspection Medicine Conference”.

Professional Association Memberships

Member of Youth Committee of the 10th Committee of the Chinese Medical Association Clinical Laboratory Medicine Branch

Director of the Clinical Laboratory Medical Diagnostic Technical Committee of the Tianjin Medical Doctor Association

Director of the Clinical Laboratory Committee of the Pulmonary Oncology Committee of China Medical Education Association

Director of the Youth Committee of the Physician Branch of Tianjin Medical Association

Member of the Standing Committee of Labeled Immunoassay of China Association for Analysis and Testing

Member of the World Chinese Society of Testing and Pathologists

Member of Tianjin Medical Association Clinical Laboratory Branch

Member of Tianjin Clinical Laboratory Quality Control Committee

Member of Tianjin Blood Transfusion Quality Control Center

Technology expert of Tianjin Market and Quality Supervision and Management Committee Medical Device

Inspector of ISO 15189 medical laboratory

Research Area And Qualification:

Tumor microenvironmental immunology

Basic and clinical application of immunohematology

Clinical laboratory design and management

ISO15189 national inspector

Reviewer of "Cancer Biology & Medicine" magazine, "Clinical Chemistry (Chinese version)" magazine, "Chinese Oncology Clinical" magazine, "Test Medicine and Clinical" magazine and "International Laboratory Medicine"

Participating writing《Thyroid Oncology》

Grant Support:

Mechanism of IL-11 promoting breast cancer metastasis in hypoxic microenvironment. 2015.01-2017.12 National Natural Science Foundation of China. NO. 81402174, Fund host

Application of nanopore-mass spectrometry combined with peptide enrichment and identification platform in early diagnosis and prognosis evaluation of pancreatic cancer. 2018.4 ~ 2021.03. Provincial key projects  NO.18JCZDJC32600, Fund host

Clinical application of serum Raman spectroscopy in patients with colon cancer. 2015.07-2018.07. Subproject of the 863 Program  NO. 2015AA021107, Fund host

Relationship between expression of IL-11 and bone metastasis in breast cancer. 2011.01-2012.12. Subject of Tianjin Medical University  NO. 2010KY36, Fund host

Young and middle-aged talents in the Cancer Hospital of Tianjin Medical University Found host. 2017.11 ~ 2022.11

Feasibility study of IL-11 and CTGF in diagnosing bone metastasis of breast cancer. Subject of Tianjin Medical University Cancer Institute and Hospital   NO. 0832, Fund host

Publications:

Zhao M, Liu Y, Liu R, Qi J, Hou Y, Chang J, Ren L*. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2018;45(6):2213-2224(IF 5.5) (Corresponding Author)

Ren L, Yu Y, Wang L, Zhu Z, Lu R, Yao Z. Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer. Oncotarget.2016 Nov 15;7(46):75763-75773. (IF 5.168)（First author）

Dong D, Jia L, Zhang L, Ma N, Zhang A, Zhou Y, Ren L*. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer. Cancer Sci. 2018 Sep;109(9):2841-2851. (IF 4.372) (Corresponding Author)

Fu Zheng, Ren Li, Wei Huiting, Lv Junqiang, Che Xuchun, Zhu Zhifeng, Jia Jing Wang Li, Lin Gang, Lu Rong, Yao Zhi. Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.[J].Journal of drug targeting,2014,22(2):146-55. (IF 3.408) （First co-author）

Li Ren, Xia Wang, Zuoliang Dong, Jun Liu, Shiwu Zhang. Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway,Med Oncol,2013, 30(3), 634. (IF: 2.92)（First author）

Zuoliang Dong, Li Ren, Li Lin, Jiang Li, Yiwen Huang, Jinhong Li, Effect of microRNA-21 on multidrug resistance reversal in A549/DDP human lung cancer cells .Molecular Medicine Reports,2015,11,1:682-690. (IF 1.922)（First co-author）

Li Lin, Li Ren, Liujing Wen, Yu Wang, Jin Qi. Effect of evodiamine on the proliferation and apotosis of A549 human lung cancer cells. Molecular Medicine Reports,2016,29. (IF 1.922) （First co-author）

Han Yue-Ting, Liu Jing-Hao, Li Yue-Guo, Cui Lin, Liu Bo-Wen, Ma Tao, Ren Li*. The peripheral lymphocyte subsets correlates with clinicopathological characteristics of breast cancer patients. Int J Clin Exp Med 2017;10(1):1251-1258. (IF 0.833) （Corresponding Author）

Jia Li，Liu Chen，Xin Ying，Zhang Aimin，Zhou Yunli, Dong Dong，Ren Li*. Evaluating EFEMP1 in Cerebrospinal Fluid and Serum as a Potential Diagnosis Biomarker for Meningiomas.Clin Lab.2017 Oct 1;63(10):1717-1722. [IF: 0.848] （Corresponding Author）

Jing-Ya Zhang, Peng Ge, Peng-Yu Zhang, Meng Zhao, Li Ren*. Role of neutrophil tolymphocyte ratio or platelet to lymphocyte ratio in prediction of bone metastasis of prostate cancer, Clin Lab,2018, Accepted (IF 0.848) (Corresponding Author)

Chen Huang, Yahui Liu, Li Ren*. Research progress of interleukin-11 in tumor. TMR Cancer, 2018, 1 (1): 2-7. (Corresponding Author).